Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis / Tiberi, S., Sotgiu, G., D'Ambrosio, L., Centis, R., Arbex, M.A., Arrascue, E.A., Alffenaar, J.W., Caminero, J.A., Gaga, M., Gualano, G., Skrahina, A., Solovic, I., Sulis, G., Tadolini, M., Guizado, V.A., De Lorenzo, S., Arias, A.J.R., Scardigli, A., Akkerman, O.W., Aleksa, A., et al.. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - 62:9(2016), pp. 1188-1190. [10.1093/cid/ciw088]

Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

SOTGIU, Giovanni;PIANA, Andrea Fausto;
2016-01-01

2016
Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis / Tiberi, S., Sotgiu, G., D'Ambrosio, L., Centis, R., Arbex, M.A., Arrascue, E.A., Alffenaar, J.W., Caminero, J.A., Gaga, M., Gualano, G., Skrahina, A., Solovic, I., Sulis, G., Tadolini, M., Guizado, V.A., De Lorenzo, S., Arias, A.J.R., Scardigli, A., Akkerman, O.W., Aleksa, A., et al.. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - 62:9(2016), pp. 1188-1190. [10.1093/cid/ciw088]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/46020
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 36
  • ???jsp.display-item.citation.isi??? 32
social impact